Overview
BCDA market data
Price History
BCDA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.23 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.50 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.78 – $2.42 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $13.6 · P/B 14.82 · P/S 31.67.
Company news
BioCardia CEO Issued Shareholder Letter To Provide Update; Milestone Includes Submission For Japan's Pharmaceutical and Medical Device Agency Approval Planned For End Of 2026; Driving To Enroll Confirmatory CardiAMP HF II Trial In USBenzinga · Jun 18, 2026, 12:15 PM
8-K filing — BioCardia, Inc. (BCDA)SEC EDGAR · Jun 18, 2026, 12:00 PM
What's Going On With BioCardia Stock Tuesday?Benzinga · Jun 9, 2026, 11:55 AM
BioCardia Announces $4.4 Million FinancingGlobenewswire Inc · Jun 8, 2026, 12:15 PM
BioCardia Sells 3,509,604 Shares At Average Price Of $1.279 On June 5; No Warrants Issued In Capital RaiseBenzinga · Jun 8, 2026, 12:15 PM
Why Is BioCardia Stock Gaining Friday?Benzinga · Jun 5, 2026, 3:15 PM
BioCardia Receives FDA Confirmation For Its Biologics Evaluation And Research On CardiAMP Cell Therapy System To Treat Ischemic Heart Failure Of Reduced Ejection FractionBenzinga · Jun 5, 2026, 12:05 PM
BioCardia Announces Presentation Of Data From CardiAMP Minimally-Invasive Chronic Myocardial Ischemia Treatment Trial Demonstrating Positive Clinical OutcomesBenzinga · May 21, 2026, 12:10 PM
BioCardia Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 15, 2026, 8:54 PM
BioCardia Q1 EPS $(0.21) Misses $(0.17) EstimateBenzinga · May 15, 2026, 12:25 PM